ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 234 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $54,386,000 | -2.5% | 1,443,738 | -27.8% | 0.72% | +15.3% |
| Q2 2017 | $55,780,000 | -18.9% | 2,000,000 | 0.0% | 0.63% | -25.7% |
| Q1 2017 | $68,760,000 | +44.5% | 2,000,000 | +21.2% | 0.84% | +17.0% |
| Q4 2016 | $47,586,000 | +87.0% | 1,650,000 | +106.2% | 0.72% | +115.5% |
| Q3 2016 | $25,448,000 | -2.0% | 800,000 | 0.0% | 0.34% | -19.5% |
| Q2 2016 | $25,968,000 | – | 800,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |